CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE

The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PAUL ALLEN SUTTON, PIOTR KARPINSKI, ELIAS NDZIE, DIMITRIS PAPOUTSAKIS, STEPHANIE MONNIER
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	PAUL ALLEN SUTTON PIOTR KARPINSKI ELIAS NDZIE DIMITRIS PAPOUTSAKIS STEPHANIE MONNIER
description	The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quina zolin-4-il]-pirrol-2,5-diona, la cual se puede utilizar, por ejemplo, para trasplante.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2009004048A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2009004048A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2009004048A3</originalsourceid><addsrcrecordid>eNqNjEEKwjAUBbtxIeodPq4U_JC2EXQZ2pQG0qSmEUxFSpG4Ei3W-2NAD-DqMcPwptErM66xTEKlc1GIjFmhVQOYIqziEoXKiQzg5BqQIpyT4ClW3JZOYi1qblgrFMbf4nAUirVaBkODuQDWzhgtOSYb2GIO4ZzPo8mtv49-8dtZtCy4zUr0w7Pz49Bf_cO_u-qUELInhBK6Y-lf0QdRmjZq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE</title><source>esp@cenet</source><creator>PAUL ALLEN SUTTON ; PIOTR KARPINSKI ; ELIAS NDZIE ; DIMITRIS PAPOUTSAKIS ; STEPHANIE MONNIER</creator><creatorcontrib>PAUL ALLEN SUTTON ; PIOTR KARPINSKI ; ELIAS NDZIE ; DIMITRIS PAPOUTSAKIS ; STEPHANIE MONNIER</creatorcontrib><description>The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quina zolin-4-il]-pirrol-2,5-diona, la cual se puede utilizar, por ejemplo, para trasplante.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090427&DB=EPODOC&CC=MX&NR=2009004048A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090427&DB=EPODOC&CC=MX&NR=2009004048A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAUL ALLEN SUTTON</creatorcontrib><creatorcontrib>PIOTR KARPINSKI</creatorcontrib><creatorcontrib>ELIAS NDZIE</creatorcontrib><creatorcontrib>DIMITRIS PAPOUTSAKIS</creatorcontrib><creatorcontrib>STEPHANIE MONNIER</creatorcontrib><title>CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE</title><description>The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quina zolin-4-il]-pirrol-2,5-diona, la cual se puede utilizar, por ejemplo, para trasplante.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAUBbtxIeodPq4U_JC2EXQZ2pQG0qSmEUxFSpG4Ei3W-2NAD-DqMcPwptErM66xTEKlc1GIjFmhVQOYIqziEoXKiQzg5BqQIpyT4ClW3JZOYi1qblgrFMbf4nAUirVaBkODuQDWzhgtOSYb2GIO4ZzPo8mtv49-8dtZtCy4zUr0w7Pz49Bf_cO_u-qUELInhBK6Y-lf0QdRmjZq</recordid><startdate>20090427</startdate><enddate>20090427</enddate><creator>PAUL ALLEN SUTTON</creator><creator>PIOTR KARPINSKI</creator><creator>ELIAS NDZIE</creator><creator>DIMITRIS PAPOUTSAKIS</creator><creator>STEPHANIE MONNIER</creator><scope>EVB</scope></search><sort><creationdate>20090427</creationdate><title>CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE</title><author>PAUL ALLEN SUTTON ; PIOTR KARPINSKI ; ELIAS NDZIE ; DIMITRIS PAPOUTSAKIS ; STEPHANIE MONNIER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2009004048A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PAUL ALLEN SUTTON</creatorcontrib><creatorcontrib>PIOTR KARPINSKI</creatorcontrib><creatorcontrib>ELIAS NDZIE</creatorcontrib><creatorcontrib>DIMITRIS PAPOUTSAKIS</creatorcontrib><creatorcontrib>STEPHANIE MONNIER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAUL ALLEN SUTTON</au><au>PIOTR KARPINSKI</au><au>ELIAS NDZIE</au><au>DIMITRIS PAPOUTSAKIS</au><au>STEPHANIE MONNIER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE</title><date>2009-04-27</date><risdate>2009</risdate><abstract>The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4 -yl]-pyrrole-2,5-dione, which may be used for example for transplantation. La invención se refiere a una nueva forma cristalina de la sal de acetato de 3-(1.H.-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quina zolin-4-il]-pirrol-2,5-diona, la cual se puede utilizar, por ejemplo, para trasplante.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; spa
recordid	cdi_epo_espacenet_MX2009004048A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	CRYSTAL MODIFICATIONS -3- (1H-IND0L-3-YL) -4- [2- (4-METHYL-PIPERAZIN-1-YL) -QUINAZOLIN-4-YL] -PYRROLE-2, 5-D IONE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A07%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAUL%20ALLEN%20SUTTON&rft.date=2009-04-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2009004048A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true